PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-34.02%
Negative revenue growth while VTLE stands at 7.41%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-49.00%
Negative gross profit growth while VTLE is at 152.88%. Joel Greenblatt would examine cost competitiveness or demand decline.
-134.64%
Negative EBIT growth while VTLE is at 17.62%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-134.64%
Negative operating income growth while VTLE is at 17.62%. Joel Greenblatt would press for urgent turnaround measures.
-438.75%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-446.30%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-442.59%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.79%
Share reduction while VTLE is at 0.19%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.01%
Reduced diluted shares while VTLE is at 0.53%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.79%
Dividend growth of 0.79% while VTLE is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-52.86%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-498.41%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-27.74%
Negative 10Y revenue/share CAGR while VTLE stands at 50.19%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-82.67%
Negative 5Y CAGR while VTLE stands at 50.19%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-69.75%
Negative 3Y CAGR while VTLE stands at 50.19%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-49.52%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-79.75%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
144.33%
Positive 3Y OCF/share CAGR while VTLE is negative. John Neff might see a big short-term edge in operational efficiency.
-198.61%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-588.16%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-129.29%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-11.04%
Negative equity/share CAGR over 10 years while VTLE stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-75.05%
Negative 5Y equity/share growth while VTLE is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-73.23%
Negative 3Y equity/share growth while VTLE is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
760.15%
Dividend/share CAGR of 760.15% while VTLE is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-48.39%
Negative 5Y dividend/share CAGR while VTLE stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-0.10%
Negative near-term dividend growth while VTLE invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-32.09%
Firm’s AR is declining while VTLE shows 6.09%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
-3.39%
Negative asset growth while VTLE invests at 4.77%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-10.50%
We have a declining book value while VTLE shows 0.26%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.36%
We’re deleveraging while VTLE stands at 11.09%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-66.01%
We cut SG&A while VTLE invests at 23.14%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.